Viewing Study NCT01937468


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-01-04 @ 10:03 PM
Study NCT ID: NCT01937468
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-11
First Post: 2013-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module